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The antimicrobial properties of dextrose-encapsulated gold nanoparticles (dGNPs) with average diameters of 25, 60,
and 120 nm (± 5) and synthesized by green chemistry principles were investigated against both Gram-negative and
Gram-positive bacteria. Studies were performed involving the effect of dGNPs on the growth, morphology, and
ultrastructural properties of bacteria. dGNPs were found to have significant dose-dependent antibacterial activity
which was also proportional to their size. Experiments revealed the dGNPs to be bacteriostatic as well as
bactericidal. The dGNPs exhibited their bactericidal action by disrupting the bacterial cell membrane which leads to
the leakage of cytoplasmic content. The overall outcome of this study suggests that green-synthesized dGNPs hold
promise as a potent antibacterial agent against a wide range of disease-causing bacteria by preventing and
controlling possible infections or diseases.
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Multidrug-resistant (MDR) bacteria represent a major
threat to the success of many branches of medical
sciences. Some patients are especially vulnerable of ac-
quiring MDR bacterial infections as a consequence of
treatments for illnesses such as organ transplant,
hemodialysis, and various types of cancer [1]. Each year
at least 150,000 people die around the world due to the
infection of a particular MDR bacterium [2]. Therefore,
there is an immense need for new strategies to design
antibacterial agents [3].
Nanoparticles (NPs) have been used to synthesize or
to improve the remedial efficacy of antibacterial agents
[4-10]. NPs for this purpose are generally synthesized by
using various metals and polymers [11,12]. ZnO nano-
particles have been used as an antibacterial agent but,
published studies also showed that ZnO nanoparticles
were toxic to T cells and neuroblastoma cells [13,14].* Correspondence: rajalingam.dakshinamurthy@wku.edu
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in any medium, provided the original work is pCopper nanoparticles have been shown as a potential
antimicrobial agent, but it also comes with the cost of
toxicity to eukaryotic cells e.g., potential damage to dor-
sal root ganglion neuron [15,16]. Similarly, silver nano-
particles have been studied extensively for their potential
antibacterial properties [17], but many concerns arises
over their use on mammalian cells due to the essential
toxicity of silver e.g., the genotoxicity towards mamma-
lian cell lines such as mouse embryonic stem cells and
mouse embryonic fibroblasts [18,19]. The use of silver
nanoparticles for medical applications is potentially
limited due to their nonspecific biological toxicity. Com-
pared to all the metal nanoparticles mentioned above,
gold nanoparticles are more amenable to surface modifi-
cation and are also photostable, and nontoxic based on
the extensive review on nanotechnology [20,21].
Thus, where the undesirable properties such as cellular
toxicity and instability of these NPs limit their applica-
tion, the gold nanoparticles (GNPs) have attracted a sig-
nificant interest because of their convenient surface
bioconjugation, remarkable plasmon-resonant optical
properties, chemical stability, and non-toxicity [22-25].
Studies have also shown that the GNPs are useful toan Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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biodistribution of the drugs which enhance the antibacterial
activity against MDR bacteria [11-14]. However, the use
of complicated non-bio/non-ecofriendly chemical syn-
thesis processes and dependence on external sources
(such as laser pulses) for the synthesis and/or the activa-
tion of GNPs limits their environmental/biocompatibility
[26-30]. Moreover, the size of the GNPs strongly influ-
ences their physical, chemical, and biological properties
[31,32]. Therefore, there is a need for GNPs with differ-
ent sizes for various biomedical applications including
those with antibacterial activity [33].
This report is focused on the antibacterial activity of
the dextrose-encapsulated gold nanoparticles (dGNPs)
which were synthesized by employing a ‘completely
green’ method as shown in our previously published
article [34]. In this context ‘green’ refers to the process in
which the dGNPs were synthesized. The green process is
completely natural allowing for the reproducible synthe-
sis of differently sized dGNPs without the need for harsh
chemicals or expensive equipment such as lasers. The
advantages of said ‘green techniques’ are linked with
natural, inexpensive, chemical stability, and ecofriendli-
ness. Three different sizes of dGNPs were synthesized
having the average diameters of 25, 60, and 120 nm
(±5). The resulting dGNPs were nearly spherical,
monodispersed, stable, and water soluble. The dGNPs
were prepared using dextrose as both reducing and
capping agent.
We explored the antibacterial activity of the dGNPs
against both Gram-negative (Escherichia coli) and
Gram-positive (Staphylococcus epidermidis) bacteria.
Investigation of the bacterial growth kinetics and growth
inhibition, in the presence of dGNPs at various concen-
trations, was performed using a real-time spectrophoto-
metric assay. Antibacterial activity and efficacy were
further validated by turbidimetry and spread plate assays.
To understand the mechanism of action, we performed
fluorescence microscopy and observed ultrathin slices of
nanoparticles-treated bacterial cells under transmission
electron microscope (TEM).
Methods
Chemicals including KAuCl4/HAuCl4, Luria-Bertani
broth, Luria broth (LB) agar, tryptic soy agar, propidium
iodide, and dextrose were purchased from Aldrich, St.
Louis, MO, USA. E. coli and S. epidermidis were pur-
chased from Invitrogen, Carlsbad, CA, USA or obtained
from Western Kentucky University’s culture collection.
Analytical grade chemicals were typically used.
Synthesis and characterization of dGNPs
Gold nanoparticles were synthesized according to our
previously published environmentally benign, biofriendly,single-step/single-phase synthesis method [34]. In this
method dextrose was used as a reducing agent as well as
a capping agent causing the reduction of Au3+ ions in an
aqueous buffer at room temperature and atmospheric
pressure. In a typical dGNPs sample, preparation process
the reaction mixture was centrifuged at 6,000 rpm for
20 min, and the supernatant was discarded. The precipi-
tated dGNPs were resuspended in autoclaved nanopure
water and then again precipitated by centrifugation (and
the supernatant was discarded). This resuspension and
precipitation processes were repeated at least four times
and then the dGNPs samples were used for further ana-
lysis. This washing procedure helped us to make sure
that the dGNPs sample does not contain any free dex-
trose or any free Au ions. The synthesized dGNPs were
characterized using various analytical techniques includ-
ing TEM analysis (Section A in Additional file 1). To de-
termine the morphology of dGNPs, the absorption spectra
were observed using Perkin Elmer Lambda 35 UV/vis
spectrophotometer (Perkin Elmer Inc., Waltham, MA,
USA). Energy dispersive spectroscopy was performed to
analyze the elemental composition of nanoparticles using
JEOL JSM 5400 LV with IXRF system (JEOL Ltd., Tokyo,
Japan). Quantification of dGNPs was performed using the
reported methods [3,34-38] (Section B in Additional
file 1). The presence of dextrose on the surface of dGNP
was further confirmed by Benedict’s test [35] (Section C in
Additional file 1).The presence of hydroxyl group was
determined by treatment with acetic anhydride and
pyridine followed by titration with sodium hydroxide
[36] (Section D Additional file 1). The more detailed
experimental procedure for quantification, Benedict’s test,
and volumetric titration are described in the additional
word file (Additional file 1).
Determination of antibacterial activity of dGNPs
The antibacterial experiments were performed using
fresh culture of bacteria obtained by inoculating 100 μL
of bacterial glycerol stock into 10 mL of sterile LB or
minimal liquid medium in a culture tube. The bacteria
were allowed to grow overnight in an incubator main-
tained at 37°C and shaken at 150 rpm. For all the experi-
ments, dGNPs were washed several times with sterile
water and then resuspended in nanopure water or
medium.
Turbidimetry
Turbidimetry refers to a microbiological assay per-
formed for measuring the minimum inhibitory concen-
tration (MIC) of dGNPs against E. coli. Various
concentrations of dGNPs with average diameters of
120 nm (2 × 1010, 4 × 1010, 8 × 1010, 16 × 1010 NPs/mL),
60 nm (2 × 1011, 4 × 1011, 8 × 1011, 16 × 1011 NPs/mL),
25 nm (16 × 1012, 32 × 1012, 64 × 1012, 128 × 1012 NPs/mL)
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ture tubes containing 4 mL of sterile liquid media. Con-
trol experiments were performed by inoculating the
media with E. coli in the absence of dGNPs. All tubes
were incubated at 37°C, and the growth of bacteria
was monitored by measuring the optical density (OD) at
600 nm for 12 h. OD 600 is an acronym indicating the
optical density of a sample measured at a wavelength of
600 nm. Optical density at 600 nm is a common method
used in molecular biology to quantify the bacteria by
determining the absorbance at 600 nm [39,40].
Spread plate technique
The bacteria (E. coli/S. epidermidis) were grown in a
series of culture tubes containing 4 mL of sterile liquid
media with various concentrations of dGNPs. Cultures
from selected concentrations and growth points (12 h)
were spread onto LB or tryptic soy agar plates and incu-
bated at 37°C for 12 h to estimate the number of viable
bacteria [41].
Fluorescence assay
The bacteria were cultured in liquid media in the pres-
ence of different concentrations of dGNPs for 12 h at
37°C. The samples were collected and centrifuged at
6,000 rpm for 3 min and washed twice with phosphateFigure 1 Effect of different sizes of dextrose-encapsulated GNPs on th
monitoring the optical density (OD) at 600 nm, and the E. coli was treated
concentrations (NPs/mL).buffered saline (PBS, pH ~ 7.2). These bacterial cells
were incubated with propidium iodide (3 μM in PBS) in
the dark for 30 min at room temperature. Fluorescence
detection was performed on 10 μL of the bacterial sus-
pension that was placed on a glass slide and observed
under Leica scanning fluorescence microscope (Leica
Microsystems, Buffalo Grove, IL, USA) [3]. Positive con-
trol was prepared by treating the bacterial suspension
with 100% ethyl alcohol for 15 min.
Preparation for cross section of the bacterial cells
Ultrastructural changes induced by dGNP treatment
were studied under an electron microscope. The cultures
of the two bacterial strains were fixed by mixing with
equal volumes of a × 2 fixative solution to give final con-
centrations of 2.0% w/v paraformaldehyde and 2.5% w/v
glutaraldehyde in 50 mM sodium cacodylate buffer (pH
7.4). After incubating with fixative for 2 h at room
temperature, the fixed samples were washed and centri-
fuged twice; the supernatant was discarded, and the pel-
let was resuspended in 50 mM sodium cacodylate buffer.
The same process was followed during all subsequent
solution changes. Samples were post-fixed for 1 h at 25°C
with 1% w/v osmium tetroxide in 50 mM sodium cacody-
late buffer. The post-fixed samples were washed with
nanopure water twice and then dehydrated in a gradede growth of E. coli. Growth analysis curves were measured by
with dGNPs of sizes: 25 ± 5; 60 ± 5. and 120 ± 5 nm at different
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thrice in 100% ethanol for 10 min each). The dehydrated
samples were infiltrated with Spurr’s epoxy resin (once in
33%, 66%, 95%, and thrice in 100% resin for 1 h each)
and then left overnight in 100% resin. The samples were
centrifuged through fresh resin in BEEM capsules (BEEM
Inc., West Chester, PA, USA) and hardened at 70°C for
18 h. Ultrathin sections of the pelleted samples were cut
on an RMC MT-X ultra-microtome using a glass knife.
The sections were stained with 2% aqueous uranyl acetate
and Reynold’s lead citrate for 15 and 3 min, respectively
and examined using a JEOL-100CX transmission electron
microscope [42,43].
Results and discussion
Recent advances in the field of nanobiotechnology have
been used for the development of new antibacterial
agents. Non-bio/ non-ecofriendly synthesis processes,
cellular toxicity, and instability of nanoparticles severely
limit the nanoparticles application. Taking this into con-
sideration, we explored the antibacterial properties of
stable, biocompatible, ecofriendly dGNPs.Figure 2 Plate assay showing the number of viable cells recovered af
treated with dGNPs in the liquid media for 12 h and then were spread on
of E. coli colonies recovered against the number of dGNPs.Synthesis and characterization of dGNPs
Three different sizes of dGNPs [25, 60, and 120 nm
(±5)] were synthesized using the previously published
method in which dextrose was used as a capping and re-
ducing agent (see Section A in Additional file 1) [34].
The dGNPs of different sizes were produced by varying
the concentrations of KAuCl4.
Antibacterial activity
In determination of the antibacterial activity of dGNPs,
we performed both liquid broth and solid agar plate-
based growth studies on E. coli. The dGNPs of different
sizes were tested for their antibacterial activity at various
concentrations against E. coli. Before performing the ac-
tual antibacterial experiment, the dGNPs were tested for
their stability by suspending the nanoparticles in sterile
liquid media in culture tube and kept in an incubator
shaker at 37°C. The dGNPs were found to be intact/
stable (no cluster/precipitation) for more than 48 h. In
the tube assay, the bacterial cells were grown in the
presence of dGNPs, and the growth was monitored
hourly by measuring the OD at 600 nm for 12 h. Opticalter treatment of E. coli with dGNPs. (A) The bacterial cells were
the agar plates and incubated for further 12 h. (B) Plot of the number
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concentration of bacterial cells in a liquid medium.
Blank samples were prepared by suspending the dGNPs
in sterile liquid medium and processed in same condi-
tion as that of the samples. Any absorption due to
dGNPs was autocorrected using a blank sample. Results
were plotted with the OD on Y-axis against the time on
X-axis (Figure 1). Both the 120-nm and 60-nm dGNPs
were found to inhibit the proliferation of E. coli, in a
concentration-dependent manner with MIC at 16 × 1010
and 16 × 1011 NPs/mL, respectively. The 25-nm dGNPs
did not significantly affect the proliferation of E. coli
even at a concentration as high as 128 × 1012 NP/mL.
The 120-nm dGNPs were found to be the most potent
antibacterial agent compared with the 60 nm which, inFigure 3 Visualization of dGNP induced morphological changes in E.
untreated E. coli cell at 0 h (a); cross section of the untreated E. coli cell aft
section of the dGNPs treated E. coli cell after 6 h showing the initiation of
(OMVs) (b); cross section of the lysed E. coli cell after 12 h of treatment wit
the initiation of disruption of cell membrane (d).turn, were more potent than the 25 nm (Figure 1). The
growth kinetic data clearly suggested that the antibacterial
activity was directly proportional to the increase in the
size of dGNPs.
The antibacterial activity exhibited by dGNPs could be
attributed to the presence of free Au3+ ions that
remained in the solution when the dGNPs were sus-
pended in water or due to changes in pH, since the bac-
terial activity is sensitive to both of these factors. To
quantify the free Au3+ ions in the suspension, the
dGNPs precipitated by centrifugation and the super-
natant was tested for the presence of free Au3+ ions
by measuring the absorbance at 290 nm. The near zero
absorbance at 290 nm showed the absence of any free
Au3+ ion (data not shown), suggesting that the free Au3+coli cell membranes under the TEM. (A) Morphology of the
er 12 h (b). (B) Interaction of dGNPs with E. coli cell at 0 h (a); cross
the cell disruption by the formation of outer membrane vesicles
h dGNPs (c); the magnified view of OMV formation, which represents
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significant and therefore, not responsible for the anti-
bacterial activity. In addition the pH of the dGNPs
suspensions was near 7.2 to 7.4 which is the normal
pH range for the microorganism environment. Hence,
the pH could not have been responsible for the anti-
bacterial activity. Taken together, the results suggested
that the antibacterial activity was solely due to the
dGNPs and not due to free Au3+ ion or changes in pH.
The results of the growth assay indicated that the
presence of dGNPs inhibited the growth of E. coli, repre-
senting the bacteriostatic property of the dGNPs. In
order to confirm whether dGNPs exhibited bactericidal
action, spread plate technique was used. The cultures in
the liquid broth that were treated with different sizes of
dGNPs for 12 h [the time required by control to reach
the stationary phase (complete growth)] were plated on
fresh LB agar media. The results given in Figure 2A,B
indicated that the number of colonies on the agar plate
significantly decreased with increase in the size of
dGNPs. The antibacterial potency of dGNPs increasedFigure 4 Monitoring dGNPs-induced permeability of E. coli cell memb
image in the differential interference contrast mode, while the right half sh
cells with permeable membranes from five or more fields of view obtainedas the size increased (25 < 60 < 120 nm). Furthermore,
the growth of the colonies on the agar plate demon-
strated that within one size of dGNPs, the bactericidal
effect was concentration dependent (Figure 2). The
above results from the agar spread plate methods con-
firmed that the dGNPs exhibited bactericidal properties.
dGNPs-induced disruption of bacterial cells
The process of the antibacterial activity of dGNPs was
determined using time-dependent action of dGNPs on
the morphology of bacterial cell and monitoring the
results. This was done by collecting the dGNP-treated
E. coli cells at different time points which were then
processed for cross-sectional analysis. The TEM ana-
lysis of the cross sections of untreated cells showed
that the membrane integrity remained intact at differ-
ent time points even after the stationary phase (after
12 h) (a and b in Figure 3A). However, bacteria treated
with 120 and 60 nm dGNPs showed gradual morpho-
logical changes within 6 h. Initially, the dGNPs were
observed to anchor onto the surface of the cell atranes and leakage of nucleic acids. (A) The left half shows an
ows the corresponding fluorescence image. (B) The percentage of
by two independent experiments.
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where the dGNPs lodged showed the formation of per-
forations or outer membrane vesicles (OMVs) on the
membrane, which eventually resulted into complete
cell lysis (b and c in Figure 3B) [44,45].
To investigate the effect of various sizes of dGNPs on
the cell permeability, cells were treated with propidium
iodide (PI). PI is a fluorescent dye which specifically
binds with nucleic acid and produces enhanced fluores-
cence. However, PI cannot cross intact membranes and
is excluded from the viable cells [3]. Thus, in the pres-
ence of PI, cells with permeable membrane (lysed or
damaged cell membrane) will fluoresce under the fluor-
escence microscope. For this study we incubated fresh
E. coli cultures with different sizes of dGNPs and then
treated with PI to assess the integrity of the cell mem-
brane. Fluorescence images showed that the permeabil-
ity of dGNP-treated bacteria was 92% for 120 nm, 87%
for 60 nm, and very minimal permeability of less than
13% for 25 nm (Figure 4A). The permeability of the cell
membrane increased significantly with exposure toFigure 5 Spread plate assays of S. epidermidis after treatment with dG
number of viable cells recovered after the treatment of S. epidermidis witho
S. epidermidis colonies recovered against the number of dGNPs.increase in the size of dGNPs and also with the in-
crease in the concentration of dGNPs (Figure 4B).
Therefore, exposure of the cells to dGNPs leads to the
disruption of the integrity of the cell membrane, caus-
ing increased permeability and possible leaching of the
cell materials. These results indicated the size-
dependent effect of the dGNPs on bacterial membrane
through the time-dependent leaching/disruption. It
must be noted that the mechanism of interaction be-
tween the cell membrane and the dGNPs needs to be
investigated.
To determine the versatile antibacterial nature of the
dGNPs, we further studied the action of dGNPs against
S. epidermidis. Staphylococcus is a genus of Gram-
positive bacteria, which resides normally on the skin and
mucous membranes of human and other organisms
causing a wide array of diseases [46-48]. Various antibac-
terial experiments were performed against S. epidermidis
similar to those performed against E. coli. Plate-based
growth studies were performed to determine the bacteri-
cidal action of dGNPs, in which the cultures in the liquidNPs at different concentrations. (A) Plate assay showing the
ut (control) or with dGNPs). (B) Graphs plotted for the number of
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12 h (complete growth) were then plated on fresh tryptic
soy agar media. The results showed similarity to the
results obtained against E. coli, indicating less number of
recovered cells with increasing size of dGNPs as well as
with increase in the concentration of particles (Figure 5).
Though having antibiotic action against both species
(E. coli and S. epidermidis), the process of action could
be different. Therefore, to determine the process of ac-
tion against S. epidermidis, TEM and fluorescence
studies were performed. TEM analysis was done by
collecting dGNPs-treated S. epidermidis cells at different
time points and was processed for cross-sectional ana-
lysis. The morphological changes were observed through
the analysis of these cross sections which clearly showed
the disruption of cell membrane at the initial phase,
which eventually lead to cell lysis (Figure 6). The fluores-
cence assay performed using PI also showed the disrup-
tion of the integrity of the cell membrane which causes
increased permeability and possible leaching of the cell
materials (Figure 7). Thus, the different types of antibac-
terial assays suggested that the antibacterial activity of
dGNPs against S. epidermidis also occurred through the
disruption of bacterial cellular membrane, similar to that
of E. coli [48].
The overall results suggested similar potency and mem-
brane disruption process for the antibacterial activity ofFigure 6 Visualizing dGNP-induced morphological changes of S. epide
S. epidermidis cells at 0 h (a); cross section of the untreated S. epidermidis c
(a); cross section of the dGNPs-treated S. epidermidis cell after 6 h showing
S. epidermidis cell after 12 h of treatment with dGNPs (c).dGNPs towards Gram-negative as well as Gram-positive
bacteria. Dextrose is a polyhydroxylated molecule, which
can act both as a hydrogen bond donor as well as a
hydrogen bond acceptor. The presence of the capping
ligand dextrose was confirmed with positive Benedict’s
test (Section C in Additional file 1). The hydroxyl group
was also detected using acetylation reaction followed by
volumetric titration with sodium hydroxide (Section D in
Additional file 1). The presence of hydroxyl group can
thus be attributed for the strong electrostatic interaction
between dGNPs and both Gram-negative or Gram-
positive bacteria, which in turn lead to the disruption of
cell membrane. Thus, this may explain the versatile anti-
bacterial activity of these dGNPs. It may be inferred
that the ligand molecule dextrose plays a crucial role in
the antibacterial action but the mechanism of interaction
remains to be established.
Conclusions
In this present work, we have investigated the antibacterial
activity of biofriendly/ecofriendly dextrose-encapsulated
GNPs of sizes 25, 60, and 120 nm (± 5). These green-
synthesized dGNPs showed significant antibacterial activity
against both Gram-negative as well as Gram-positive bac-
teria. The efficiency of antibacterial activity was directly
proportional to the increase in size as well as the concen-
tration of dGNPs. These dGNPs were found to exert theirrmidis cell membranes via TEM. (A) Morphology of the untreated
ell after 12 h (b). (B) Interaction of dGNPs with S. epidermidis cell at 0 h
the initiation of the cell wall disruption (b); cross section of the lysed
Figure 7 Monitoring of dGNPs-induced permeability of S. epidermidis cell membranes via propidium iodide. (A) For each image the left
half shows an image in the differential interference contrast mode, while the right half shows the corresponding fluorescence image. (B) The
percentage of cells with permeable membranes from five or more fields of view obtained by two independent experiments.
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leading to possible leakage of the cytoplasmic contents in-
cluding nucleic acids. Based on the results, it is plausible
that the amphoteric nature of dextrose (the capping lig-
and) might be responsible for the interaction of dGNPs
with both the Gram-positive and Gram-negative bacteria
which, in turn, leads to the antibacterial activity. The anti-
bacterial properties of the dGNPs hold promise for
pharmaceutical, disinfectant, and other biomedical applica-
tions. The molecular level interaction between the cell
membrane and the dGNPs that causes membrane rupture
remains to be established.Additional file
Additional file 1: Detailed description of the experimental
procedures for quantification, Benedict’s test, and volumetric
titration. The additional file 1 contains the TEM images for three
different sizes of dGNPs along with the description of quantification ofdGNPs. The presence of dextrose on the surface of dGNPs was
determined using the Benedict’s test which has been discussed along
with the experimental results. Moreover, the additional file contains a
brief discussion over the volumetric titration that was performed to
determine the presence of unreduced hydroxyl group.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
VDB, LMV, DP, CW, and DR synthesized the different sizes of GNPs. VDB, LMV,
CW, ZA, and DR characterized GNPs using TEM and performed UV/vis
spectroscopy and all the antibacterial assays. All authors read and approved
the final manuscript.
Acknowledgments
We are grateful to Dr. John Andersland for TEM analysis. The project was
supported in part by Department of Chemistry, Advanced Materials Institute,
Ogden College of Science and Engineering, Office of Sponsored Programs at
Western Kentucky University and grants from the National Center for
Research Resources (5P20RR016481-12) and the National Institute of General
Medical Sciences (8 P20 GM103436-12) from the National Institutes of Health
and National Science Foundation Research Experience for Undergraduates
Badwaik et al. Nanoscale Research Letters 2012, 7:623 Page 10 of 11
http://www.nanoscalereslett.com/content/7/1/623(REU) grant number EAR-1004655. The honors college grant to DSP and the
graduate student research grants to VDB and LMV are also appreciated.
Author details
1Department of Chemistry, Western Kentucky University, Bowling Green, KY
4210, USA. 2Ocean Nano Tech, Springdale, AR 72764, USA.
Received: 6 August 2012 Accepted: 31 October 2012
Published: 12 November 2012
References
1. So AD, Gupta N, Brahmachari SK, Chopra I, Munos B, Nathan C, Outterson K,
Paccaud JP, Payne DJ, Peeling RW, Spigelman M, Weigelt J: Towards new
business models for R&D for novel antibiotics. Drug Resist Update 2011,
14:89–94.
2. Salerno F, Cazzaniga M: Therapeutic strategies and emergence of
multiresistant bacterial strains. Intern Emerg Med 2010, 5:45–51.
3. Zhao Y, Tian Y, Cui Y, Liu W, Ma W, Jiang J: Small molecule-capped gold
nanoparticles as potent antibacterial agents that target gram-negative
bacteria. J Am Chem Soc 2010, 132:12349–12356.
4. Balland O, Pinto-Alphandary H, Viron A, Puvion E, Andremont A, Couvreur P:
Intracellular distribution of ampicillin in murine macrophages infected
with Salmonella typhimurium and treated with (3H) ampicillin-loaded
nanoparticles. J Antimicrob Chemother 1996, 37:105–115.
5. Rosemary MJ, MacLaren I, Pradeep T: Investigations of the antibacterial
properties of ciprofloxacin@SiO2. Langmuir 2006, 22:10125–10129.
6. Rosi NL, Giljohann DA, Thaxton CS, Lytton-Jean AK, Han MS, Mirkin CA:
Oligonucleotide-modified gold nanoparticles for intracellular gene
regulation. Science 2006, 312:1027–1030.
7. Thomas M, Klibanov AM: Conjugation to gold nanoparticles enhances
polyethylenimine’s transfer of plasmid DNA into mammalian cells.
Proc Natl Acad Sci USA 2003, 100:9138–9143.
8. Cho EC, Au L, Zhang Q, Xia Y: The effects of size, shape, and surface
functional group of gold nanostructures on their adsorption and
internalization by cells. Small 2010, 6:517–522.
9. Bowman MC, Ballard TE, Ackerson CJ, Feldheim DL, Margolis DM, Melander
C: Inhibition of HIV fusion with multivalent gold nanoparticles. J Am
Chem Soc 2008, 130:6896–6897.
10. Gu H, Ho PL, Tong E, Wang L, Xu B: Using biofunctional magnetic
nanoparticles to capture vancomycin-resistant Enterococci and other
gram-positive bacteria at ultralow concentration. Nano Lett 2003,
3:1261–1263.
11. Buzea C, Pacheo I, Robbie K: Nanomaterials and nanoparticles: sources
and toxicity. Biointerphases 2007, 2:2815690–2815745.
12. Nair LS, Laurencin CT: Role of size scale of ZnO nanoparticles and
microparticles on toxicity towards bacteria and osteoblast cancer cells.
J Biomed Nanotechnol 2007, 3:301–316.
13. Reddy KM, Feris K, Bell J, Wingett DG, Hanley C, Punnoose A: Selective
toxicity of zinc oxide nanoparticles to prokaryotic and eukaryotic
systems. Appl Phy Lett 2007, 90:213902.
14. Jeng HA, Swanson J: Toxicity of metal oxide nanoparticles in mammalian
cells. J Enviorn Sci Health 2006, 41:2699.
15. Ruparelia JP, Chatterjee AK, Duttagupta SP, Mukherji S: Strain specificity in
antimicrobial activity of silver and copper nanoparticles. Acta Biomater
2008, 4:707–716.
16. Prabhu BM, Ali SF, Murdock RC, Hussain SM, Srivatsan M: Copper
nanoparticles exert size and concentration dependent toxicity on
somatosensory neurons of rat. Nanotoxicology 2010, 4:150–160.
17. Morones JR, Elechiguerra JL, Camacho A, Holt K, Kouri JB, Ramirez JT,
Yacaman M: The bactericidal effect of silver nanoparticles.
J. Nanotechnology. 2005, 16:2346–2353.
18. Ahamed M, Karns M, Goodson M, Rowe J, Hussain SM, Schlager JJ, Hong Y:
DNA damage response to different surface chemistry of silver
nanoparticles in mammalian cells. Toxicol Appl Pharmacol 2008,
233:404–410.
19. Norman RS, Stone JW, Gole A, Murphy CJ, Sabo ATL: Targeted
photothermal lysis of the pathogenic bacteria, Pseudomonas aeruginosa,
by gold nanorods. Nano Lett 2008, 8:302–306.
20. Panyala N, Pena-Mendze E, Havel J: Silver or silver nanoparticles: a
hazardous threat to the environment and human health? Jour of App
Biomed. 2008, 6:117–129.21. Love JC, Estroff LA, Kriebel JK, Nuzzo RG, Whitesides GM: Self-assembled
monolayers of thiolates on metals as a form of nanotechnology. Chem
Rev 2005, 105:1103–1170.
22. Cheng CMM, Cuda G, Bunimovich LY, Gaspari M, Heath RJ, Hill DH, Mirkin
AC, Nijdam JA, Terracciano R, Thundat T, Ferrari M: Nanotechnologies for
biomolecular detection and medical diagnostics. Curr Opin Chem Biol
2006, 10:11–19.
23. Hu M, Chen J, Li ZY, Au L, Hartland GV, Li X, Marqueze M, Xia Y: Gold
nanostructures: engineering their plasmonic properties for biomedical
applications. Chem Soc Rev 2006, 35:1084–1094.
24. Shim SY, Lim DK, Nam JM: Ultrasensitive optical biodiagnostic methods
using metallic nanoparticles. Nanomedicine 2008, 3:215–232.
25. Huang WC, Tsai PJ, Chen YC: Functional gold nanoparticles as
photothermal agents for selective-killing of pathogenic bacteria.
Nanomedicine 2007, 2:777–787.
26. Kovtun A, Heumann R, Epple M: Calcium phosphate nanoparticles for the
transfection of cells. Biomed Mater Eng 2009, 19:241–247.
27. Bunz UH, Rotello VM: Gold nanoparticle-fluorophore complexes: sensitive
and discerning “noses” for biosystems sensing. Angew Chem Int Ed Engl
2010, 49:3268–3279.
28. Wu W, Li AD: Research focus: optically switchable nanoparticles for
biological imaging. Nanomedicine 2007, 2:523–531.
29. Liao HW, Nehl CL, Hafner JH: Biomedical applications of plasmon
resonant metal nanoparticles. Nanomedicine 2006, 1:201–208.
30. Erathodiyil N, Ying JY: Functionalization of inorganic nanoparticles for
bioimaging applications. Acc Chem Res 2011, 44:925–935.
31. Kelly LK, Coronado E, Zhao L, Schatz GC: The optical properties of metal
nanoparticles: the influence of size, shape, and dielectric environment.
J Phys Chem B 2003, 107:668–677.
32. Auffan M, Bottero YJ, Chaneac C, Rose J: Inorganic manufactured
nanoparticles: how their physicochemical properties influence their
biological effects in aqueous environments. Nanomedicine 2010,
5:999–1007.
33. Pal S, Yu KT, Song M: Does the antibacterial activity of silver nanoparticles
depend on the shape of the nanoparticle? A study of the gram-negative
bacterium Escherichia coli. J Appl Environ Microbiol 2007, 73:1712–1720.
34. Badwaik DV, Bartonojo JJ, Evans WJ, Sahi VS, Willis BC, Dakshinamurthy R:
Single-step bio-friendly synthesis of surface modifiable, near-spherical
gold nanoparticles for applications in biological detection and catalysis.
Langmuir 2011, 27:5549–5554.
35. Robert DS, Robert LH, Martha V: Benedict’s solution, a reagent for
measuring reducing sugars: the clinical chemistry of Stanley R. Benedict J
Biol Chem 1908, 5:485–487.
36. Vernon LP, Edward SW: The volumetric estimation of hydroxyl groups in
sugars and other organic compounds. J Biol Chem 1927, 74:379–383.
37. Daniel MC, Ruiz J, Nlates S, Blais JC, Astrus D: Nanoscopic assemblies
between supramolecular redox active metallodendrons and gold
nanoparticles: synthesis, characterization, and selective recognition of
H2PO4
−, HSO4
−, and adenosine-50-triphosphate (ATP2−) anions. J Am Chem
Soc 2003, 125:2617–2628.
38. Leff DV, Ohara PC, Heath JR, Gelbart WM: Crystallization of opals from
polydisperse nanoparticles. J Phys Chem 1995, 99:7036–7041.
39. Chamundeeswari M, Sobhana LSS, Jacob PJ, Kumar GM, Devi PM, Sastry PT,
Mandal BA: Preparation, characterization and evaluation of a
biopolymeric gold nanocomposite with antimicrobial activity. Biotechnol
Appl Biochem 2010, 55:29–35.
40. Burygin LG, Khlebtsov NB, Shantrokha NA, Dykman AL, Bogatyrev AV,
Khlebtsov GN: On the enhanced antibacterial activity of antibiotics mixed
with gold nanoparticles. Nanoscale Res Lett 2009, 4:794–801.
41. Shrivastava S, Bera T, Roy A, Singh G, Ramachandrarao P, Dash D:
Characterization of enhanced antibacterial effects of novel silver
nanoparticles. Nanotechnology 2007, 18:225103–225112.
42. Santhana RL, Hing HL, Baharudin O, Teh HZ, Aida SR, Nor ACP, Vimala B,
Paramsarvaran S, Sumarani G, Hanjeet K: Rapid method for transmission
electron microscope study of Staphylococcus aureus ATCC 25923. Ann
Microscope 2007, 7:102–108.
43. Jung KW, Koo CH, Kim WK, Shin S, Kim HS, Park HY: Antibacterial activity
and mechanism of action of the silver ion in Staphylococcus aureus and
Escherichia coli. Appl Environ Microbiol 2008, 74:2171–2178.
44. Kadurugamuwa JL, Clarke AJ, Beveridge TJ: Surface action of gentamicin
on Pseudomonas aeruginosa. J Bacteriology 1993, 175:5798–5805.
Badwaik et al. Nanoscale Research Letters 2012, 7:623 Page 11 of 11
http://www.nanoscalereslett.com/content/7/1/62345. Vaara M: Agents that increase the permeability of the outer membrane.
Microbiol Rev 1992, 56:395–411.
46. Lowy DF: Staphylococcus aureus infections. N Engl J Med 1998,
339:520–532.
47. Ryan KJ, Ray CG: An introduction to infectious diseases. Medical
Microbiology. 2004, 4:345–347.
48. Ndeke M, Melusi T, Nomakhwezi N: The antibacterial effects of engineered
nanomaterials: implications for wastewater treatment plants. J Enviorn
Monitor 2011, 13:1164–1183.
doi:10.1186/1556-276X-7-623
Cite this article as: Badwaik et al.: Size-dependent antimicrobial
properties of sugar-encapsulated gold nanoparticles synthesized by a
green method. Nanoscale Research Letters 2012 7:623.Submit your manuscript to a 
journal and beneﬁ t from:
7 Convenient online submission
7 Rigorous peer review
7 Immediate publication on acceptance
7 Open access: articles freely available online
7 High visibility within the ﬁ eld
7 Retaining the copyright to your article
    Submit your next manuscript at 7 springeropen.com
